Allenex

Stockholm, Sweden Founded: 1998 • Age: 28 yrs Acquired By CareDx
Transplantation diagnostic kits for matching and rejection prevention are developed.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Allenex

Allenex is a company based in Stockholm (Sweden) founded in 1998 was acquired by CareDx in December 2015. Allenex operates in a competitive market with competitors including BioLife Solutions, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.

  • Headquarter Stockholm, Sweden
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    CareDx

    (Dec 16, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Allenex

Premium access

Detailed funding history for Allenex

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Allenex

Allenex has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CareDx.

All
Institutional
Investor Description Founded Year Domain Location
Medical solutions for transplant patients are developed and provided.
Locked Locked Locked
Premium access

Investor details for Allenex

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Allenex

Investments
Premium access

Investment portfolio details for Allenex

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Allenex

Premium access

Detailed financials for Allenex

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Allenex Comparisons

Allenex Primary company
Description
Transplantation diagnostic kits for matching and rejection p...
Location
Stockholm, Sweden
Founded Year
1998
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Allenex

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Allenex

Allenex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioLife Solutions, Sino Biological, GenScript, OncoDNA and Fluent BioSciences, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Tissue hypothermic storage and cryopreservation freeze media are developed.
Locked Locked Locked
Reagents and kits are provided for clinical research applications.
Locked Locked Locked
Reagents and instruments are provided for life sciences research.
Locked Locked Locked
Genomic and theranostic services for oncology precision medicine are delivered.
Locked Locked Locked
Proprietary reagents for single-cell genetic analysis are developed.
Locked Locked Locked
Speech recognition solutions are provided by Inscripta for healthcare professionals.
Premium access

Detailed competitors of Allenex

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Allenex

Premium access

Complete news archive for Allenex

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Allenex

Allenex was founded in 1998.

Allenex is headquartered in Stockholm, Sweden.

Allenex was founded in 1998 in Stockholm, Sweden, within the biotechnology sector focused on transplantation diagnostics. PCR-based kits under the Olerup SSP line are utilized for HLA matching in hematopoietic stem cell and organ transplants. XM-One assays are applied to detect antibodies targeting HLA Class I or II antigens or donor endothelium, supporting rejection avoidance. The company was acquired by CareDx in April 2016.

Allenex's top competitors include Sino Biological, OncoDNA and RoosterBio.

Allenex has 1 investor. Key investors include CareDx.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available